In this follow-up to the previous Doc Gumshoe missive about cancer, entitled “Cancer 2023 – What’s Happening in the Combat Zone,” which posted on July 18, we’ll be discussing several general types of cancer – brain, lung, ovarian, breast, liver, and cancer caused by obesity. In each case, however, there are special conditions associated with […]

Just over 50 years ago, President Richard M. Nixon signed into law the National Cancer Act of 1971, which established the National Cancer Institute. Cancer had become the second leading (after heart disease) cause of death in the US in 1970. The National Cancer Institute (NCI) from its establishment had broad powers, including the creation […]

New ads pitch a special report called "Three Ways to Make Triple-Digit Gains on Flash-Radioimmunotherapy," and we've got the Thinkolator results ... plus, a note about the also-teased "Incredible Weight-Loss Drug"

Monkeypox, progress against cancer... and yes, a little COVID-19 update ,too

Will this latest tease benefit from the "Historic biotech merger wave?"

Most of this Doc Gumshoe posting was ready to go a couple of days before Thanksgiving. But then, you know what happened: the new variant (now named Omicron) surfaced in South Africa. So I finished up another Doc Gumshoe epistle that I had been working on and quickly got it to Travis so I could […]

Doc Gumshoe on progress in vaccines, treatments and immunity

Doc Gumshoe on Arizona, Sweden, Herd Immunity and the Progress of Vaccine Programs

Doc Gumshoe on "a few encouraging items"

Mostly in these Doc Gumshoe pieces I try to keep my focus on what the physicians and researchers and pharmaceutical outfits are doing to try to treat, or at least manage, all these diseases, ailments, and conditions that affect our lives.   But other issues keep thrusting themselves into the picture, especially the cost factor. […]

Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]

Part Two of Doc Gumshoe's look at Cancer in 2019

What's being teased by Mike Burnick's Infinite Income?

Doc Gumshoe looks at the state of cancer treatment... and some of the interesting drug approvals from 2018

Most of the attention in the media is now focused on the several forms of cancer treatment grouped under the flattering term “Precision Medicine.”   I find that the term raises my skepticism index just a bit; it’s like eating establishments labeling themselves “Gourmet Restaurants,” the implication being that joints not so identified are just […]

Doc Gumshoe follows up...

Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me.   Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy?   But I probably pay more attention to […]

What's being teased by Nilus Mattive's The Rich Life?

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

Baking soda, Alzheimer's, oncolytic viruses, measles, and more...

What drugs hit in 2017? How did approvals compare to 2016?

[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]

[ed note: Michael Jorrin, who I like to call “Doc Gumshoe,” writes non-investment articles for us about medical and health topics a couple times a month. He is a medical writer, not a doctor, and his words and thoughts are his own.] Just possibly a tiny few of the Gumshoe faithful may remember that advertising […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]

Oh Yeah...It May Prevent Cancer, Too

[Ed. Note: Dr. KSS writes about biotech stocks for the Irregulars. We have not reviewed or approved his topics or opinions, and he has agreed to our trade restrictions. Enjoy!] Twenty years ago, I was living life on an extreme slant as a medicine resident. My routine was a rut of working 36 hours, having […]

Here's to a "Green" Biotechnology Company....In A Manner of Speaking

DR. KSS TAKES ON ANTIBIOTICS